MIT scientists have created a method to "paint" GLP-1 drugs onto antibodies inside the body, achieving longer-lasting effects ...

Omada Health is joining forces with CVS Health's Caremark as part of the pharmacy benefit manager's weight management program ...

Shares of the health and wellness platform operator skyrocketed more than 670% between Jan. 1, 2024, and Feb. 19, 2025.

Sen. Jim Banks (R-Ind.) wants the Food and Drug Administration to look into foreign-made active pharmaceutical ingredients he ...

Is the era of sourcing cheaper weight loss drugs from the internet over? High demand for GLP-1 agonists — prescription drugs ...

The rapid rise of GLP-1 weight-loss drugs has come with a raucous side show—a wave of copycat drugs unbound by drug patents. The knockoff surge was led by Hims & Hers Health, the telehealth firm ...

are developing small-molecule weight-loss candidates with the goal of marketing a once-a-day pill. Most pills under development target GLP-1, the same receptor that the peptide drugs target.

Compounding pharmacies will have to stop producing copycats of tirzepatide, the active ingredient in the blockbuster weight loss drugs Mounjaro ... akin to other GLP-1 medications such as semaglutide.

was curious about the ads he saw promising to reverse his hair loss. He completed a 14-question intake on Hims.com and received a bottle of finasteride pills days later. He never spoke to a doctor.

GLP-1 drugs, also known as incretin treatments ... developing next-generation treatments with stronger weight-loss effects. Others, like Hims & Hers (HIMS), betted on more affordable off-brand ...

The trial demonstrated significant weight loss results with minimal side effects, marking a crucial product development milestone. During the trial, participants experienced weight loss ranging from 5 ...

Most compounded versions of popular drugs ... 1 drugs will impact many people who have found the compound versions of the drugs easier to access and lower in price. Semaglutide (GLP-1) weight-loss ...